Data Foundry

Drug recalls 2012

Daytrana — Class II drug recall D-1653-2012

Terminated recall by Noven Pharmaceuticals, Inc., reported 2012-08-29, distributed nationwide. Miscalibrated and/or Defective Delivery System: Out of Specification results for mechanical peel force and/or

Recall numberD-1653-2012
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmNoven Pharmaceuticals, Inc., Miami, FL, United States
Recall initiated2012-07-12
Classified2012-08-17
Reported by FDA2012-08-29
Terminated2014-08-04
DistributedNationwide (US)
Quantity177,900 patches
Reason classesspecification failure
NDC68968-5552, 68968-5552-03, 68968-5553, 68968-5553-03, 68968-5554, 68968-5554-03, 68968-5555, 68968-5555-03
Lot numbers12/12, 55302

Product

Daytrana (methylphenidate) transdermal system patch, Delivers 20 mg over 9 hours (2.2 mg/hr), 1 patch per pouch, packaged in 30-count patches per box, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc., Miami, FL 33186; NDC 68968-5554-3.

Reason for recall

Miscalibrated and/or Defective Delivery System: Out of Specification results for mechanical peel force and/or the z-statistic value which relates to the patient's ability to remove the release liner from the patch adhesive prior to administration.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1653-2012. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.